未登录Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung Cancer病理完全缓解预测III期非小细胞肺癌新辅助诱导化疗及放化疗后的长期生存率
Guberina, Maja; Metzenmacher, Martin; Pottgen, Christoph; Wiesweg, Marcel; Guberina, Nika; Merkel-jens, Anja; Lutke-brintrup, Diana; Bolukbas, Servet; Eberhardt, Wilfried E. E.; Stamatis, Georgios; Doerr, Fabian; Plones, Till; Hoffmann, Christian; Zaun, Gregor; Hoing, Benedikt; Kurten, Cornelius; Mladenov, Emil; Iliakis, George; Kersting, David; Fendler, Wolfgang P.; Gauler, Thomas; Opitz, Marcel; Milosevic, Aleksandar; Forsting, Michael; Nensa, Felix; Umutlu, Lale; Funke, Faustina; Hautzel, Hubertus; Herrmann, Ken; Taube, Christian; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin .png)
分享.png)
收藏Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)Schulte, Christina; Gauler, Thomas; Poettgen, Christoph; Friedel, Godehard; Kopp, Hans-Georg; Fischer, Berthold; Schmidberger, Heinz; Kimmich, Martin; Budach, Wilfried; Cordes, Sebastian; Wienker, Johannes; Metzenmacher, Martin; de los Rios, Rodrigo Hepp; Spengler, Werner; De Ruysscher, Dirk; Belka, Claus; Welter, Stefan; Luetke-Brintrup, Diana; Guberina, Maja; Oezkan, Filiz; Darwiche, Kaid; Schuler, Martin; Joeckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried Ernst Erich 分享 收藏 Long-term survival of patients with central or >7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatmentGuberina, Nika; Poettgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Ploenes, Till; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Darwiche, Kaid; Aigner, Clemens; Eberhardt, Wilfried E. E.; Stuschke, Martin 分享 收藏 分享 收藏 Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy诱导化疗后容积PET/CT参数对接受确定性放化疗的IIIA或IIIB期非小细胞肺癌患者的预后价值Guberina, Maja; Poettgen, Christoph; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Aigner, Clemens; Ploenes, Till; Umutlu, Lale; Gauler, Thomas; Darwiche, Kaid; Stamatis, Georgios; Theegarten, Dirk; Hautzel, Hubertus; Jentzen, Walter; Guberina, Nika; Herrmann, Ken; Eberhardt, Wilfried E. E.; Stuschke, Martin 分享 收藏 Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improveGuberina, Nika; Poettgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Ploenes, Till; Krebs, Bettina; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Joeckel, Karl-Heinz; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Eberhardt, Wilfried E. 分享 收藏 Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer - Secondary Analysis of a Randomized Phase 3 TrialGuberina, M.; Stuschke, M.; Eberhardt, W.; Gauler, T.; Aigner, C.; Schuler, M.; Stamatis, G.; Dirk, T.; Jentzen, W.; Herrmann, K.; Poettgen, C. 分享 收藏 Lymph Node Involvement and the Surgical Treatment of Thymic Epithelial and Neuroendocrine CarcinomaCheufou, Danjouma Housmanou; Valdivia, Daniel; Puhlvers, Stephan; Fels, Benjamin; Weinreich, Gerhard; Taube, Christian; Theegarten, Dirk; Stuschke, Martin; Schuler, Martin; Hegedus, Balazs; Stamatis, Georgios; Aigner, Clemens 分享 收藏 Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trialGuberina, Maja; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Theegarten, Dirk; Jentzen, Walter; Herrmann, Ken; Poettgen, Christoph 分享 收藏 分享 收藏 分享 收藏 Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trialGuberina, M.; Eberhardt, W.; Stuschke, M.; Gauler, T.; Heinzelmann, F.; Cheufou, D.; Kimmich, M.; Friedel, G.; Schmidberger, H.; Darwiche, K.; Jendrossek, V.; Schuler, M.; Stamatis, G.; Pottgen, C. 分享 收藏 分享 收藏 Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factorsPoettgen, Christoph; Stuschke, Martin; Graupner, Britta; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, Eleni; Wohlschlaeger, Jeremias; Welter, Stefan; Hoiczyk, Matthias; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried 分享 收藏 分享 收藏 Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C): Results From a Multicenter Phase III StudyStuschke, M.; Poettgen, C.; Gauler, T.; Friedel, G.; Veit, S.; Heinrich, V.; Welter, S.; Spengler, W.; Schmidberger, H.; Luetke-Brintrup, D.; Lehmann, N.; Joeckel, K.; Schuler, M.; Stamatis, G.; Eberhardt, W. 分享 收藏 Thoracic Staging in Lung Cancer: Prospective Comparison of 18F-FDG PET/MR Imaging and 18F-FDG PET/CT肺癌的胸部分期: 18F-FDG PET/MR成像和18F-FDG PET/CT的前瞻性比较Heusch, Philipp; Buchbender, Christian; Koehler, Jens; Nensa, Felix; Gauler, Thomas; Gomez, Benedikt; Reiss, Henning; Stamatis, Georgios; Kuehl, Hilmar; Hartung, Verena; Heusner, Till A. 分享 收藏 Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine TumoursMairinger, Fabian Dominik; Walter, Robert Fred Henry; Theegarten, Dirk; Hager, Thomas; Vollbrecht, Claudia; Christoph, Daniel Christian; Worm, Karl; Ting, Saskia; Werner, Robert; Stamatis, Georgios; Mairinger, Thomas; Baba, Hideo; Zarogoulidis, Konstantinos; Huang, Haidong; Li, Qiang; Tsakiridis, Kosmas; Zarogoulidis, Paul; Schmid, Kurt Werner; Wohlschlaeger, Jeremias 分享 收藏 Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterWiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Joerg; Gauler, Thomas C.; Koehler, Jens; Eberhardt, Wilfried E.; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbuecher, Frank; Wohlschlaeger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lutkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt W.; Schuler, Martin 分享 收藏 Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionationPoettgen, C.; Eberhardt, W.; Graupner, B.; Theegarten, D.; Gauler, T.; Freitag, L.; Abu Jawad, J.; Wohlschlaeger, J.; Welter, S.; Stamatis, G.; Stuschke, M. 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
